The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Bayer AG, and Aventis S.A, In the Matter of
A consent order permits Bayer to purchase Aventis CropScience Holdings S.A. from Aventis S.A. The order requires Bayer to divest businesses and assets in the following four major markets: new generation chemical insecticide products: new- generation chemical insecticide active ingredients; post-emergent grass herbicides for spring wheat; and cool weather cotton defoliants. According to the complaint, the transaction as proposed would result in the elimination of both actual and competition in the four markets; increase barriers to entry; reduce innovation competition for certain products; and increase the possibility of coordinated interaction between competitors.
20030359: ALLTEL Corporation; Cellular North Michigan Network General Partnership
20030357: Nissho Iwai Corporation; Nichimen Corporation
20030356: Nichimen Corporation; Nissho Iwai Corporation
20030349: Forrester Research, Inc.; Giga Information Group, Inc.
20030345: The Coca-Cola Company; Coca-Cola Enterprises Inc.
20030342: Manulife Financial Corporation; Canada Life Financial Corporation
20030328: Pearson plc; The McGraw-Hill Companies, Inc.
0302004 Informal Interpretation
20030354: Prudential Financial, Inc.; Skandia Insurance Company Ltd. (publ)
20030353: Heartland Industrial Partners, L.P.; Linsalata Capital Partners Fund II, L.P.
20030343: Level 3 Communications, Inc.; Carl C. Icahn
20030340: Fidelity National Financial, Inc.; ANFI, Inc.
20030280: Verizon Communications Inc.; Cablevision Systems Corporation
20030189: The Lundbeck Foundation; Synaptic Pharmaceutical Corporation
0302003 Informal Interpretation
Baxter International Inc., and Wyeth, In the Matter of
Baxter settled Commission concerns stemming from its $316 million proposed acquisition of Wyeth Corporation's generic injectable drug business and agreed to divest several pharmaceutical products. The Commission charged that the acquisition would reduce competition in the manufacture and sale of propofol (a general anesthetic); new injectable iron replacement therapies; metocloprarnide (used to treat nausea); and vecuronium and pancuronium (neuromuscular blocking agents used to temporarily freeze muscles during surgery). The consent order requires divestitures in each of the pharmaceutical markets.